vs

Side-by-side financial comparison of Blend Labs, Inc. (BLND) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $32.4M, roughly 1.8× Blend Labs, Inc.). Blend Labs, Inc. runs the higher net margin — -7.8% vs -83.0%, a 75.2% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 7.6%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 16.6%).

GU Energy Labs is a company based in Berkeley, California, that produces sports nutrition products, most notably energy gels. Often consumed during endurance events, the gels are designed to be quickly and easily digested during any type of activity. Other products include energy chews, drink mixes, hydration tablets, stroopwafels and a Roctane line that includes an energy drink mix, protein recovery drink mix, gel, and capsules. The company was founded in 1994 by Bill Vaughan, who began crea...

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

BLND vs RYTM — Head-to-Head

Bigger by revenue
RYTM
RYTM
1.8× larger
RYTM
$57.3M
$32.4M
BLND
Growing faster (revenue YoY)
RYTM
RYTM
+29.3% gap
RYTM
36.9%
7.6%
BLND
Higher net margin
BLND
BLND
75.2% more per $
BLND
-7.8%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
16.6%
BLND

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BLND
BLND
RYTM
RYTM
Revenue
$32.4M
$57.3M
Net Profit
$-2.5M
$-47.5M
Gross Margin
75.7%
91.6%
Operating Margin
-11.1%
-82.2%
Net Margin
-7.8%
-83.0%
Revenue YoY
7.6%
36.9%
Net Profit YoY
-207.0%
-9.6%
EPS (diluted)
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLND
BLND
RYTM
RYTM
Q4 25
$32.4M
$57.3M
Q3 25
$32.7M
$51.3M
Q2 25
$31.6M
$48.5M
Q1 25
$26.8M
$32.7M
Q4 24
$30.1M
$41.8M
Q3 24
$33.1M
$33.3M
Q2 24
$28.7M
$29.1M
Q1 24
$23.8M
$26.0M
Net Profit
BLND
BLND
RYTM
RYTM
Q4 25
$-2.5M
$-47.5M
Q3 25
$12.1M
$-52.9M
Q2 25
$-6.8M
$-46.6M
Q1 25
$-9.5M
$-49.5M
Q4 24
$-825.0K
$-43.3M
Q3 24
$-2.4M
$-43.6M
Q2 24
$-19.4M
$-32.3M
Q1 24
$-20.7M
$-141.4M
Gross Margin
BLND
BLND
RYTM
RYTM
Q4 25
75.7%
91.6%
Q3 25
74.3%
89.3%
Q2 25
73.8%
88.6%
Q1 25
70.8%
88.8%
Q4 24
74.2%
90.9%
Q3 24
74.0%
88.5%
Q2 24
70.9%
89.9%
Q1 24
67.3%
89.2%
Operating Margin
BLND
BLND
RYTM
RYTM
Q4 25
-11.1%
-82.2%
Q3 25
-16.4%
-102.6%
Q2 25
-15.3%
-93.4%
Q1 25
-29.7%
-143.7%
Q4 24
-10.9%
-98.6%
Q3 24
-34.1%
-132.0%
Q2 24
-45.5%
-139.2%
Q1 24
-89.0%
-538.7%
Net Margin
BLND
BLND
RYTM
RYTM
Q4 25
-7.8%
-83.0%
Q3 25
37.0%
-103.1%
Q2 25
-21.6%
-96.1%
Q1 25
-35.5%
-151.4%
Q4 24
-2.7%
-103.6%
Q3 24
-7.4%
-131.2%
Q2 24
-67.6%
-110.9%
Q1 24
-86.7%
-544.4%
EPS (diluted)
BLND
BLND
RYTM
RYTM
Q4 25
$-0.73
Q3 25
$0.02
$-0.82
Q2 25
$-0.75
Q1 25
$-0.81
Q4 24
$-0.03
$-0.71
Q3 24
$-0.03
$-0.73
Q2 24
$-0.09
$-0.55
Q1 24
$-0.09
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLND
BLND
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$68.3M
$388.9M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$-30.5M
$139.1M
Total Assets
$170.0M
$480.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLND
BLND
RYTM
RYTM
Q4 25
$68.3M
$388.9M
Q3 25
$77.3M
$416.1M
Q2 25
$88.3M
$291.0M
Q1 25
$104.8M
$314.5M
Q4 24
$94.2M
$320.6M
Q3 24
$112.3M
$298.4M
Q2 24
$108.9M
$319.1M
Q1 24
$121.1M
$201.2M
Total Debt
BLND
BLND
RYTM
RYTM
Q4 25
$0
Q3 25
$0
Q2 25
$0
Q1 25
$0
Q4 24
$0
Q3 24
$0
Q2 24
$0
Q1 24
$138.9M
Stockholders' Equity
BLND
BLND
RYTM
RYTM
Q4 25
$-30.5M
$139.1M
Q3 25
$-13.4M
$148.8M
Q2 25
$-23.1M
$-11.9M
Q1 25
$-17.2M
$18.9M
Q4 24
$-56.4M
$21.7M
Q3 24
$-49.6M
$11.2M
Q2 24
$-45.5M
$39.3M
Q1 24
$-35.8M
$61.6M
Total Assets
BLND
BLND
RYTM
RYTM
Q4 25
$170.0M
$480.2M
Q3 25
$188.6M
$506.9M
Q2 25
$182.2M
$372.7M
Q1 25
$187.5M
$386.7M
Q4 24
$178.1M
$392.3M
Q3 24
$186.1M
$363.6M
Q2 24
$185.4M
$381.8M
Q1 24
$201.8M
$258.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLND
BLND
RYTM
RYTM
Operating Cash FlowLast quarter
$1.5M
$-25.4M
Free Cash FlowOCF − Capex
$-21.0K
FCF MarginFCF / Revenue
-0.1%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-81.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLND
BLND
RYTM
RYTM
Q4 25
$1.5M
$-25.4M
Q3 25
$-3.6M
$-26.6M
Q2 25
$-6.5M
$-23.3M
Q1 25
$20.1M
$-40.4M
Q4 24
$-4.6M
$-18.8M
Q3 24
$2.1M
$-25.2M
Q2 24
$-6.7M
$-29.1M
Q1 24
$-3.9M
$-40.7M
Free Cash Flow
BLND
BLND
RYTM
RYTM
Q4 25
$-21.0K
Q3 25
$-5.8M
Q2 25
$-10.1M
Q1 25
$15.8M
Q4 24
$-7.1M
Q3 24
$-1.4M
Q2 24
$-8.5M
Q1 24
$-5.8M
FCF Margin
BLND
BLND
RYTM
RYTM
Q4 25
-0.1%
Q3 25
-17.6%
Q2 25
-31.9%
Q1 25
58.9%
Q4 24
-23.5%
Q3 24
-4.1%
Q2 24
-29.7%
Q1 24
-24.5%
Capex Intensity
BLND
BLND
RYTM
RYTM
Q4 25
4.8%
Q3 25
6.5%
Q2 25
11.4%
Q1 25
16.1%
Q4 24
8.3%
Q3 24
10.4%
Q2 24
6.5%
Q1 24
8.2%
Cash Conversion
BLND
BLND
RYTM
RYTM
Q4 25
Q3 25
-0.30×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLND
BLND

Mortgage Suite$18.9M58%
Consumer Banking Suite$11.4M35%
Professional Services$2.1M6%

RYTM
RYTM

Segment breakdown not available.

Related Comparisons